Using Stem Cells And Bioengineered Scaffolds To Promote Regeneration Following Necrotic Brain Injury
Funder
National Health and Medical Research Council
Funding Amount
$710,857.00
Summary
A number of injuries, including stroke, result in tissue loss. Consequently promoting repair will require restoration of tissue structure, replacement cells and a supportive environment to promote integration of these new cells. This study will engineer and develop novel scaffolds that can replace tissue whilst additionally providing physical and chemical support for newly implanted stem cells. This work will be conducted in an animal model of stroke.
Standardising Protocols For The Differentiation And Integration Of Human Pluripotent Stem Cell-derived Neural Transplants In Parkinson's Disease
Funder
National Health and Medical Research Council
Funding Amount
$987,664.00
Summary
Clinical trials have shown that transplanting dopamine neurons (specific nerve cells) into the brain of Parkinson’s disease patients can improve symptoms. Trials use fetal tissue for implantation, which is unsustainable and highly variable. This proposal will examine stem cells as an alternative. We will establish a reliable protocol to instruct human stem cells to become dopamine neurons, develop methods to select these cells and, examine the integration of these transplanted cells in the brain
Pre-Clinical Studies Towards Cell-Based Approaches For Cortical Repair.
Funder
National Health and Medical Research Council
Funding Amount
$739,901.00
Summary
This project seeks to determine whether brain cells that die after stroke can be functionally replaced using cells grown in the laboratory from human stem cells. Current therapies for stroke aim to limit the damage but do not allow for actual recovery of brain function. By growing turning stem cells into specialised cells that match the ones lost after stroke, this project aims to restore motor function by transplanting these cells into the injured brain.
This proposal seeks to determine the therapeutic potential of stem cells for the treatment of brain injury early in life, for example as occurs in cerebral palsy. The project will test the capacity of implanted stem cells to both protect the brain and also to functionally replace cells lost to the injury in order to improve motor and cognitive function.
Pre-clinical Steps Towards A Stem Cell Therapy For Parkinson's Disease.
Funder
National Health and Medical Research Council
Funding Amount
$1,179,594.00
Summary
A promising experimental therapy for Parkinson's disease is the use of stem cells that in order to replace the cells lost during the disease process. A challenge for this approach is that upon transplantation into the brain, in addition to the therapeutic cell types, there will also be unwanted cell types such as those that can form tumours. This proposal seeks to establish a novel strategy for removing those cells prior to transplantation.
Selective Isolation And In Vivo Properties Of Dopamine Neurons Generated From Embryonic Stem Cells.
Funder
National Health and Medical Research Council
Funding Amount
$505,389.00
Summary
This research aims to develop a procedure that allows for the safe and effective use of stem cells as a therapy for Parkinson’s disease. It is based on the concept that new dopamine neurons, generated from stem cells, can be implanted into the brain of the patients in order to replace those lost to the disease, thereby improving motor function.
Identification Of Novel Regulatory Factors In Midbrain Development To Improve Cell Therapies For The Treatment Of Parkinson’s Disease
Funder
National Health and Medical Research Council
Funding Amount
$311,860.00
Summary
Cell transplantation is one of the most promising therapeutic strategies for the treatment of Parkinson’s disease. Cells are transplanted directly into the brain of the patient and can compensate for those lost to the disease. In this project we are identifying new genes that regulate the normal development of the transplanted cells in mice. We hope to use this knowledge to improve the reliability and effectiveness of the approach, bringing the therapy closer to the clinic.
Enhancement Of Newborn Neuron Survival To Promote Repair Following Adult Brain Injury
Funder
National Health and Medical Research Council
Funding Amount
$555,780.00
Summary
Following brain damage tissue needs to be rebuilt and newborn nerve cells need to survive. Identification of factors that enhance the numbers and promote the survival and appropriate integration of newborn nerve cells is therefore important and over the last few years we have identified two regulatory factors that are prime candidates to enhance numbers and survival of newborn neurons following injury: the Rho pathway and suppressor of cytokine signalling-2, which we will test for effectiveness ....Following brain damage tissue needs to be rebuilt and newborn nerve cells need to survive. Identification of factors that enhance the numbers and promote the survival and appropriate integration of newborn nerve cells is therefore important and over the last few years we have identified two regulatory factors that are prime candidates to enhance numbers and survival of newborn neurons following injury: the Rho pathway and suppressor of cytokine signalling-2, which we will test for effectiveness following brain injury.Read moreRead less
Defining The Function Of Two Discrete Precursor Cell Populations In The Adult Hippocampus: Potential For The Treatment Of Cognitive And Mood Disorders
Funder
National Health and Medical Research Council
Funding Amount
$578,985.00
Summary
Adult hippocampal neurogenesis plays a crucial role in fundamental cognitive processes such as learning and memory formation and mood regulation. Our laboratory has identified two discrete pools of quiescent stem and precursor cells in the adult hippocampus that can be activated by distinct mechanisms. This study will examine the functional properties of new neurons generated from these discrete pools and their role in improving behavioural outcomes associated with cognition and mood regulation
I am a neurologist and neuroscientist studying the causes and mechanisms of Parkinson's disease and the physiology in health and diseases of the nervous system affected by movement disorders